Dr. Alex M Horchak, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1500 Delhi St, Suite 4300, Dubuque, IA 52001 Phone: 563-557-5971 Fax: 563-557-5973 |
Dr. James Joseph Voelker, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1500 Delhi St, Ste 4300, Dubuque, IA 52001 Phone: 563-557-5971 Fax: 563-557-5973 |
Raymond Farlow Roewe Jr., Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3490 Fax: 563-584-3215 |
George K. Kraemer, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3490 Fax: 563-584-3177 |
John Thomas Dolehide, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3490 Fax: 563-584-3177 |
News Archive
CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it will evaluate the approval of potential anti-arrhythmic claims for Ranexa (ranolazine extended-release tablets) as part of its ongoing review of the Company's supplemental new drug application (sNDA).
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced that Emdeon Clinician™ has been certified to meet Stage 1 Certification Criteria for Meaningful Use of Electronic Health Record (EHR) Technology by the Drummond Group Inc. Emdeon Clinician is a component of Emdeon Office Suite™, which allows healthcare providers to tap into Emdeon's vast network of payers, providers, labs and pharmacies for clinical, financial and administrative healthcare transactions.
Genentech, Inc., a member of the Roche Group today announced results from a Phase II clinical study of RG7204 (PLX4032), an investigational first-in-class molecule designed to selectively inhibit a cancer-causing, mutated form of the BRAF protein found in approximately half of metastatic melanoma tumors.
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center are the first in the region to have joined a nationwide clinical trial to evaluate the effectiveness of a gene therapy in patients with advanced melanoma which is aimed to help a patient ' s own immune system fight their cancer.
› Verified 2 days ago